Aethlon Medical Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2023	2022	2021	2020	2019	2018 - 2010
Net Income	-12.21	-12.03	-10.42	-7.89	-6.37	Upgrade
Depreciation & Amortization	0.36	0.27	0.15	0.04	0.03	Upgrade
Share-Based Compensation	1.22	1.05	0.75	0.78	0.84	Upgrade
Other Operating Activities	0.5	0.21	-0.26	0.3	0.31	Upgrade
Operating Cash Flow	-10.13	-10.51	-9.77	-6.76	-5.2	Upgrade
Capital Expenditures	-0.25	-0.94	-0.35	-0.06	-0.15	Upgrade
Investing Cash Flow	-0.25	-0.94	-0.35	-0.06	-0.15	Upgrade
Share Issuance / Repurchase	1.32	8.93	17.46	7.26	12.16	Upgrade
Debt Issued / Paid	0	0	0	0	-0.99	Upgrade
Other Financing Activities	-0.03	-0.01	-0.09	-0.13	-0.04	Upgrade
Financing Cash Flow	1.29	8.91	17.37	7.13	11.13	Upgrade
Exchange Rate Effect	0	-0.01	0	0	0	Upgrade
Net Cash Flow	-9.09	-2.54	7.25	0.3	5.78	Upgrade
Free Cash Flow	-10.38	-11.45	-10.12	-6.82	-5.35	Upgrade
Free Cash Flow Margin	-	-1993.62%	-3439.01%	-1035.47%	-822.73%	Upgrade
Free Cash Flow Per Share	-4.13	-5.57	-6.86	-5.64	-15.66	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).